📣 VC round data is live. Check it out!
- Public Comps
- Cofoe Medical
Cofoe Medical Valuation Multiples
Discover Cofoe Medical's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like PROCEPT BioRobotics, Nakanishi, Immunocore Holdings, Weigao Group and more.
Cofoe Medical Overview
About Cofoe Medical
Cofoe Medical Technology Co Ltd is engaged in the research and development, production, sales and service of home medical equipment.
Founded
2009
HQ

Employees
N/A
Website
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialCofoe Medical Financials
Cofoe Medical reported last 12-month revenue of $544M and EBITDA of $98M.
In the same LTM period, Cofoe Medical generated $293M in gross profit, $98M in EBITDA, and $60M in net income.
Revenue (LTM)
Cofoe Medical P&L
In the most recent fiscal year, Cofoe Medical reported revenue of $501M and EBITDA of $93M.
Cofoe Medical is profitable as of last fiscal year, with gross margin of 53%, EBITDA margin of 18%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
Cofoe Medical Stock Performance
Cofoe Medical has current market cap of $2B, and enterprise value of $1B.
Market Cap Evolution
Cofoe Medical's stock price is $6.47.
Cofoe Medical share price decreased by 1.5% in the last 30 days, and increased by 34.2% in the last year.
Cofoe Medical has an EPS (earnings per share) of $0.23.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $2B | -1.8% | -1.5% | -21.5% | 34.2% | $0.23 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCofoe Medical Valuation Multiples
Cofoe Medical trades at 2.4x EV/Revenue multiple, and 13.1x EV/EBITDA.
EV / Revenue (LTM)
Cofoe Medical Financial Valuation Multiples
As of June 3, 2026, Cofoe Medical has market cap of $2B and EV of $1B.
Cofoe Medical has a P/E ratio of 25.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cofoe Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cofoe Medical Margins & Growth Rates
Cofoe Medical grew revenue by 23% and EBITDA by 25% in the last fiscal year.
In the most recent fiscal year, Cofoe Medical reported gross margin of 53%, EBITDA margin of 18%, and net margin of 11%.
Cofoe Medical Margins
Cofoe Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cofoe Medical Operational KPIs
Cofoe Medical's Rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cofoe Medical's Rule of X is 75% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Cofoe Medical Competitors
Cofoe Medical competitors include PROCEPT BioRobotics, Nakanishi, Immunocore Holdings, Weigao Group, El.En. Group, BoneSupport, Savaria, Haier Biomedical, SKAN Group and Qingdao Baheal Medical.
Most Cofoe Medical public comparables operate across Medical Devices, HealthTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.4x | 3.9x | (27.0x) | (34.2x) | |||
| 2.5x | 2.4x | 10.3x | 9.9x | |||
| 2.7x | 2.6x | (298.4x) | (47.1x) | |||
| 5.6x | 5.3x | 16.1x | 16.6x | |||
| 1.8x | 1.8x | 11.9x | 11.4x | |||
| 11.9x | 10.7x | 57.4x | 44.0x | |||
| 2.4x | 2.3x | 11.6x | 11.2x | |||
| 3.6x | 3.5x | 21.3x | 21.2x | |||
This data is available for Pro users. Sign up to see all Cofoe Medical competitors and their valuation data. Start Free Trial | ||||||
Cofoe Medical VC Funding History
Before going public, Cofoe Medical raised $4M in total equity funding, across 3 rounds.
Cofoe Medical Funding Rounds
Acquisitions by Cofoe Medical
Cofoe Medical has acquired 3 companies to date.
Last acquisition by Cofoe Medical was on December 27th 2022. Cofoe Medical acquired Laihe Biotech for undisclosed valuation.
Latest Acquisitions by Cofoe Medical
| Description | Laihe Biotech is a Hangzhou-based biotechnology company advancing point-of-care testing (POCT) devices for real-time diagnostics of infectious diseases and chronic conditions. Its Lyher.com platform commercializes fluorescence immunoassay analyzers and test kits for COVID-19, cardiac markers, and tumor biomarkers. The firm operates a 10,000-square-meter R&D and manufacturing facility compliant with GMP standards. Founded in 2010, Laihe Biotech supplies systems to hospitals and clinics across Asia and exports to Southeast Asia. | Acorn International is a Shanghai-based marketing company operating in China's digital media landscape, with divisions in product sales, content distribution, and influencer management. The Product Division sells consumer goods via Tmall and JD.com platforms alongside offline channels. Acorn Streaming in the Content Division produces live and video-on-demand for platforms like Douyin. The Influencer Division represents U.S. celebrities for Weibo and Xiaohongshu presence. Publicly listed on NYSE until 2022, it leverages 20 years of direct marketing expertise. | Jirui Medical is a high-tech manufacturer of electric wheelchairs, scooters, and rehabilitation equipment in China. The company integrates R&D, production, and sales to supply mobility solutions for medical and daily use. |
| HQ Country | |||
| HQ City | Hangzhou | Shanghai | Shanghai |
| Deal Date | 27 Dec 2022 | 3 Mar 2022 | 8 Nov 2021 |
| Valuation | undisclosed | undisclosed | $8M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Cofoe Medical acquisitions and their M&A valuation multiples. Start Free Trial | |||
Investments by Cofoe Medical
Cofoe Medical has invested in 1 company to date.
Latest investment by Cofoe Medical was on December 25th 2025. Cofoe Medical invested in Resvent in their Series B round.
Latest Investments by Cofoe Medical
| Description | Resvent is a Shenzhen-headquartered medical device company founded in 2015, focusing on respiration and ventilation solutions including sleep therapy, critical care ventilators, and cloud-based systems. |
| HQ Country | |
| HQ City | - |
| Deal Date | 25 Dec 2025 |
| Round | Series B |
| Raised | undisclosed |
| Investors | Cofoe Medical |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Cofoe Medical investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cofoe Medical
| When was Cofoe Medical founded? | Cofoe Medical was founded in 2009. |
| Where is Cofoe Medical headquartered? | Cofoe Medical is headquartered in China. |
| Is Cofoe Medical publicly listed? | Yes, Cofoe Medical is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Cofoe Medical? | Cofoe Medical trades under 301087 ticker. |
| When did Cofoe Medical go public? | Cofoe Medical went public in 2021. |
| Who are competitors of Cofoe Medical? | Cofoe Medical main competitors include PROCEPT BioRobotics, Nakanishi, Immunocore Holdings, Weigao Group, El.En. Group, BoneSupport, Savaria, Haier Biomedical, SKAN Group, Qingdao Baheal Medical. |
| What is the current market cap of Cofoe Medical? | Cofoe Medical's current market cap is $2B. |
| What is the current revenue of Cofoe Medical? | Cofoe Medical's last 12 months revenue is $544M. |
| What is the current revenue growth of Cofoe Medical? | Cofoe Medical revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Cofoe Medical? | Current revenue multiple of Cofoe Medical is 2.4x. |
| What is the current EBITDA of Cofoe Medical? | Cofoe Medical's last 12 months EBITDA is $98M. |
| What is Cofoe Medical's EBITDA margin? | Cofoe Medical's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Cofoe Medical? | Current EBITDA multiple of Cofoe Medical is 13.1x. |
| How many companies Cofoe Medical has acquired to date? | As of June 2026, Cofoe Medical has acquired 3 companies. |
| What was the largest acquisition by Cofoe Medical? | $8M acquisition of Jirui Medical on 8th November 2021 was the largest M&A Cofoe Medical has done to date. |
| What companies Cofoe Medical acquired? | Cofoe Medical acquired Jirui Medical, Laihe Biotech, and Acorn International. |
| In how many companies Cofoe Medical has invested to date? | As of June 2026, Cofoe Medical has invested in 1 company. |
| What was the last Cofoe Medical investment? | On 25th December 2025 Cofoe Medical invested in Resvent, participating in a Series B round. |
| In what companies Cofoe Medical invested in? | Cofoe Medical invested in Resvent. |
See public comps similar to Cofoe Medical
Lists including Cofoe Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
